Previous 10 | Next 10 |
Gainers: Ever-Glory International Group (NASDAQ:EVK) +122%. Infinity Pharmaceuticals (NASDAQ:INFI) +33%. Exicure (NASDAQ:XCUR) +34%. Xenetic Biosciences (NASDAQ:XBIO) +31%. Atlas Technical Consultants (NASDAQ:ATCX) +28%. Annovis Bio (NYSE:ANVS) +22%. Full Truck Alliance (NYSE:YMM) +21%. Allie...
Gainers: Exicure (NASDAQ:XCUR) +38%, Infinity Pharmaceuticals (NASDAQ:INFI) +26%, Ra Medical Systems (NYSE:RMED) +22%, Galmed Pharmaceuticals (NASDAQ:GLMD) +22%, Lava Therapeutics (NASDAQ:LVTX) +18%. Losers: TG Therapeutics (NASDAQ:TGTX) -24%,...
Galmed Pharmaceuticals (NASDAQ:GLMD) perks up 8% premarket after announcing that the FDA has agreed with its plan to use Aramchol meglumine (in lieu of Aramchol free acid) in its Phase 3 ARMOR study without the need to conduct additional nonclinical and clinical studies other than p...
FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study - FDA agreed that Galmed can proceed with its proposed clinical studies with Aramchol meglumine in lieu of Aramchol free acid without the nee...
Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5 PR Newswire TEL AVIV, Israel , July 29, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical...
Ra Medical Systems (RMED) +56%.Liminal BioSciences (LMNL) +42%.NextDecade Corporation (NEXT) +30%.U.S. Concrete (USCR) +28% as Vulcan Materials buys the Company in $1.3B deal.QTS Realty Trust (QTS) +20% on being acquired by Blackstone funds for $78/share.ChromaDex Corporation (CDXC)...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back to the start of another busy week of trading, investors! We’re kicking off the week with a look at the biggest pre-market stock movers for Monday! Source: f11photo/Shutterstock.com But before we ...
Galmed Pharmaceuticals Ltd. (GLMD) Q1 2021 Earnings Conference Call May 13, 2021, 08:30 AM ET Company Participants Allen Baharaff - President & Chief Executive Officer Liat Hayardeny - Chief Scientific Officer Yohai Stenzler - Chief Financial Officer Conference Call Participants Steve See...
Galmed (GLMD): Q1 GAAP EPS of -$0.38 beats by $0.01.Cash and cash equivalents, restricted cash, short-term deposits and marketable debt securities totaled $58.9 million as of March 31, 2021, compared to $50.9 million at December 31, 2020.Press Release For further details see: Galmed EPS...
Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial Results - Conference Call and Webcast Today at 8:30 a.m. ET / 5:30 a.m. PT - PR Newswire TEL AVIV, Israel , May 13, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nas...
News, Short Squeeze, Breakout and More Instantly...
Galmed Pharmaceuticals Ltd. Company Name:
GLMD Stock Symbol:
NASDAQ Market:
Galmed Pharmaceuticals Ltd. Website: